Autopsy report · NCT04241718

A Feasibility Study on Ultrafiltration and Blood Volume Measurements

“Slow enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Nuwellis, Inc.

Sponsor type

Industry

Conditions

Acute Decompensated Heart Failure; Fluid Overload

Interventions

Aquadex FlexFlow System and BVA-100

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.